About: 5-APDB

An Entity of Type: drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA.

Property Value
dbo:abstract
  • 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA. In animal studies, 5-APDB's effects generalize most closely to non-stimulant MDMA analogues such as MBDB and MMAI, while producing no substitution for LSD or amphetamine. In vitro studies show that 5-APDB acts as a highly selective serotonin releasing agent (SSRA), with IC50 values of 130 nM, 7,089 nM, and 3,238 nM for inhibiting the reuptake of serotonin, dopamine, and norepinephrine, respectively. In contrast, 6-APDB is more balanced on the three monoamine neurotransmitters and acts more similarly to MDA and MDMA. Methoxy-substituted analogues of 5-APDB and 6-APDB have also been made and substituted for DOM in animal tests, although they were around one tenth as potent as DOM. (en)
dbo:casNumber
  • 152624-03-8
dbo:fdaUniiCode
  • UI10BAJ8SH
dbo:pubchem
  • 192601
dbo:thumbnail
dbo:wikiPageID
  • 20119063 (xsd:integer)
dbo:wikiPageLength
  • 5786 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1000542489 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:c
  • 11 (xsd:integer)
dbp:casNumber
  • 152624 (xsd:integer)
dbp:chemspiderid
  • 167143 (xsd:integer)
dbp:h
  • 15 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:legalCa
  • Schedule I (en)
dbp:legalDe
  • NpSG (en)
dbp:legalUk
  • Class B (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 192601 (xsd:integer)
dbp:routesOfAdministration
  • Oral (en)
dbp:smiles
  • Cl.CCCc1cc2CCOc2cc1 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • BZKLFXQUBIRXAK-UHFFFAOYSA-N (en)
dbp:unii
  • UI10BAJ8SH (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 477223997 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA. (en)
rdfs:label
  • 5-APDB (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License